Search by Drug Name or NDC

    NDC 76394-3811-03 Fludeoxyglucose F 18 40 mCi/mL Details

    Fludeoxyglucose F 18 40 mCi/mL

    Fludeoxyglucose F 18 is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by University of California, Los Angeles. The primary component is FLUDEOXYGLUCOSE F-18.

    Product Information

    NDC 76394-3811
    Product ID 76394-3811_eec89f5e-783b-d6ac-e053-2a95a90abdc4
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Fludeoxyglucose F 18
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fludeoxyglucose F 18
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 40
    Active Ingredient Units mCi/mL
    Substance Name FLUDEOXYGLUCOSE F-18
    Labeler Name University of California, Los Angeles
    Pharmaceutical Class Radioactive Diagnostic Agent [EPC], Radiopharmaceutical Activity [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203811
    Listing Certified Through 2024-12-31

    Package

    NDC 76394-3811-03 (76394381103)

    NDC Package Code 76394-3811-3
    Billing NDC 76394381103
    Package 30 mL in 1 VIAL, MULTI-DOSE (76394-3811-3)
    Marketing Start Date 2013-06-27
    NDC Exclude Flag N
    Pricing Information N/A
    << 76394-2642-03 76394-3812-01 >>

    Contents